Park Medi World Limited
Park Medi World Limited (PARKHOSPS) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Hospital
parkhospital.in(opens the company website in a new tab)Key metrics
Price as of 2026-09-04
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Sales | 410 Cr | 460 Cr | 476 Cr |
| Operating expenses (approx.) | 311 Cr | 333 Cr | 350 Cr |
| EBITDA | 99 Cr | 127 Cr | 126 Cr |
| OPM % | 24.2% | 27.7% | 26.5% |
| Other income | 9 Cr | 8 Cr | 8 Cr |
| Interest | 15 Cr | 14 Cr | 10 Cr |
| Depreciation | 15 Cr | 18 Cr | 19 Cr |
| Profit before tax | 78 Cr | 103 Cr | 105 Cr |
| Tax % | 32.5% | 25.7% | 15.7% |
| Net profit | 53 Cr | 77 Cr | 89 Cr |
| EPS (₹) | ₹1.35 | ₹1.78 | ₹2.05 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 1,679 Cr | Sign in for TTM |
| Operating expenses (approx.) | 1,235 Cr | Sign in for TTM |
| EBITDA | 444 Cr | Sign in for TTM |
| OPM % | 26.5% | Sign in for TTM |
| Other income | 32 Cr | Sign in for TTM |
| Interest | 59 Cr | Sign in for TTM |
| Depreciation | 62 Cr | Sign in for TTM |
| Profit before tax | 355 Cr | Sign in for TTM |
| Tax % | 22.9% | Sign in for TTM |
| Net profit | 274 Cr | Sign in for TTM |
| EPS (₹) | ₹6.87 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 86 Cr |
| Reserves | 2,006 Cr |
| Borrowings | 228 Cr |
| Other liabilities | 481 Cr |
| Total liabilities | 2,813 Cr |
| Fixed assets (net) | 788 Cr |
| CWIP | 123 Cr |
| Investments | 0.13 Cr |
| Inventories | 3 Cr |
| Trade receivables | 593 Cr |
| Cash & bank | 237 Cr |
| Other assets | 1,069 Cr |
| Total assets | 2,813 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 329 Cr |
| Cash from investing | -333 Cr |
| Cash from financing | 121 Cr |
| Net cash flow | 116 Cr |
| Free cash flow (OCF − Capex) | 209 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2026 |
|---|---|
| ROCE % | 17.7% |
| ROE % | 12.3% |
| Debtor days | 129 |
| Inventory days | 4 |
| Days payable | 134 |
| Cash conversion cycle | -2 |
| Debt / equity | 0.11 |
| Current ratio | 2.06 |
| Net debt / EBITDA | -0.02 |
Compare with peers
Loading peers…